FIRST AMENDMENT OF SUBLICENSE AGREEMENT
Exhibit 10.2
FIRST AMENDMENT OF SUBLICENSE AGREEMENT
THIS
FIRST AMENDMENT OF SUBLICENSE AGREEMENT (this "First Amendment") is
executed as of May 31 2019, by and between CGI Cellerate RX, LLC, a
Texas limited liability company, having its principle place of
business at 0000 Xxxxxx Xxxxxxxxx, Xxxxxxxx XX, Xxxxx 000, Xxxxxx,
XX 00000 (“Sublicensor”), and Cellerate, LLC,
a Texas limited liability company having its principal place of
business at 0000 Xxxxxx Xxxxxx, Xxxxx 000, Xxxx Xxxxx Xxxxx 00000,
(“Sublicensee”).
Sublicensor and Sublicensee are sometimes each referred to herein
as a “Party” and collectively, as the
“Parties
RECITALS
On
August 27, 2018, Sublicensor and Sublicensee entered into that
certain agreement whereby Sublicensor granted an exclusive,
non-revocable, transferrable right in and to the Licensed IP to
sell, export, market and distribute, Products for Wound Care
(including, without limitation, the Products listed on Schedule A
attached hereto) within the Territory in the Field of Use (the
“Sublicense”) to Sublicensee to be effective the 28th
day of August, 2018, (the “Effective Date”).
It is
mutually understood and agreed by and between the Parties that as
of this date Subsection 1.1 is changed to read as
follows:
1.1 “Territory” means the human Wound
Care Market and surgical market in the world, and such future
additions as may be agreed to by the Parties.
All
other terms and conditions that are not hereby amended are to
remain in full force and effect.
CGI
Cellerate RX, LLC,
as
Sublicensor
By /s/ Xxxxxxx
Xxxxxxxx
Xxxx
Xxxxxxxx
Vice
President
CELLERATE,
LLC,
as
Sublicensee
By /s/ J. Xxxxxxx
Xxxxxxx
Xxxx
Xxxxxxx
President
